NCT00745875 - ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Non Small Cell Lung CancerLung Cancer

Interventions

DRUG

ZD4054

10mg oral tablet, once daily

DRUG

Pemetrexed

500mg2/m IV infusion

DRUG

Placebo

10mg oral tablet, once daily

Trial Locations (13)

research Site, Pleven

Research Site, Sofia

Research Site, Varna

Research Site, Jičín

Research Site, Prague

Research Site, Cedex

Research Site, Strasbourg

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Chernivtsi

Research Site, Kiev

Research Site, Sumy

Research Site, Uzngorod